Abstract
Purpose
Primary immunodeficiencies (PIDs) are a large group of diseases characterized by susceptibility to not only recurrent infections but also autoimmune diseases and malignancies. The aim of this study was to describe and analyze the distribution, clinical features and eventual outcome of PID among Tunisian patients.
Methods
We reviewed the record of 710 patients diagnosed with Primary Immunodeficiency Diseases (PIDs) from the registry of the Tunisian Referral Centre for PIDs over a 25-year period.
Results
The male-to-female ratio was 1.4. The median age at the onset of symptoms was 6 months and at the time of diagnosis 2 years. The estimated prevalence was 4.3 per 100,000 populations. The consanguinity rate was found in 58.2 % of families. According to the International Union of Immunological Societies classification, spectrums of PIDs were as follows: combined T-cell and B-cell immunodeficiency disorders account for the most common category (28.6 %), followed by congenital defects of phagocyte (25.4 %), other well-defined immunodeficiency syndromes (22.7 %), predominant antibody deficiency diseases (17.7 %), diseases of immune dysregulation (4.8 %), defect of innate immunity (0.4 %) and complement deficiencies (0.4 %). Recurrent infections, particularly lower airway infections (62.3 %), presented the most common manifestation of PID patients. The overall mortality rate was 34.5 %, mainly observed with combined immunodeficiencies.
Conclusion
The distribution of PIDs was different from that reported in Western countries, with a particularly high proportion of Combined Immunodeficiencies and phagocyte defects in number and/or function. More is needed to improve PID diagnosis and treatment in our country.
Similar content being viewed by others
References
Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2011;2:54. doi:10.3389/fimmu.2011.00054.
Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2009;29(3):343–51. doi:10.1007/s10875-008-9260-x.
Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, et al. First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998–2012). J Clin Immunol. 2014;34(4):459–68. doi:10.1007/s10875-014-0005-8.
Naidoo R, Ungerer L, Cooper M, Pienaar S, Eley BS. Primary immunodeficiencies: a 27-year review at a tertiary paediatric hospital in cape Town, South Africa. J Clin Immunol. 2011;31(1):99–105. doi:10.1007/s10875-010-9465-7.
Stray-Pedersen A, Abrahamsen TG, Froland SS. Primary immunodeficiency diseases in Norway. J Clin Immunol. 2000;20(6):477–85.
CEREDIH. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135(2):264–72. doi:10.1016/j.clim.2010.02.021.
Modell V, Gee B, Lewis DB, Orange JS, Roifman CM, Routes JM, et al. Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res. 2011;51(1):61–70. doi:10.1007/s12026-011-8241-y.
Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27(5):517–24. doi:10.1007/s10875-007-9105-z.
Shabestari MS, Maljaei SH, Baradaran R, Barzegar M, Hashemi F, Mesri A, et al. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran. J Clin Immunol. 2007;27(5):510–6. doi:10.1007/s10875-007-9101-3.
Gathmann B, Binder N, Ehl S, Kindle G. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2012;167(3):479–91. doi:10.1111/j.1365-2249.2011.04542.x.
Aghamohammadi A, Moein M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, et al. Primary immunodeficiency in Iran: first report of the national registry of PID in children and adults. J Clin Immunol. 2002;22(6):375–80.
Bejaoui M, Barbouche MR, Sassi A, Larguche B, Miladi N, Bouguerra A, et al. Primary immunodeficiency in Tunisia: study of 152 cases. Archives de Pedia Organe Officiel de la Soc francaise de Pediat. 1997;4(9):827–31.
Condino-Neto A, Sorensen RU, Gomez Raccio AC, King A, Espinosa-Rosales FJ, Franco JL. Current state and future perspectives of the Latin american Society for immunodeficiencies (LASID). Allergol Immunopathol. 2014. doi:10.1016/j.aller.2014.05.007.
Modell V, Knaus M, Modell F, Roifman C, Orange J, Notarangelo LD. Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery. Immunol Res. 2014;60(1):132–44. doi:10.1007/s12026-014-8498-z.
Lamia S, Aloulou H, Kamoun T, Chabchoub I, Ben Moustapha I, Barbouch R, et al. Primary immunodeficiency disorders in 51 cases. La Tunisie medicale. 2013;91(1):38–43.
Matamoros Flori N, Mila Llambi J, Espanol Boren T, Raga Borja S, Fontan CG. Primary immunodeficiency syndrome in Spain: first report of the national registry in children and adults. J Clin Immunol. 1997;17(4):333–9.
Lee WI, Kuo ML, Huang JL, Lin SJ, Wu CJ. Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J Clin Immunol. 2005;25(2):162–73. doi:10.1007/s10875-005-2822-2.
Rhim JW, Kim KH, Kim DS, Kim BS, Kim JS, Kim CH, et al. Prevalence of primary immunodeficiency in Korea. J Korean Med Sci. 2012;27(7):788–93. doi:10.3346/jkms.2012.27.7.788.
Takada H. Primary immunodeficiency in Japan; epidemiology, diagnosis, and pathogenesis. Pediat Int Off J Japan Pediat Soc. 2013;55(6):671–4. doi:10.1111/ped.12224.
Gathmann B, Goldacker S, Klima M, Belohradsky BH, Notheis G, Ehl S, et al. The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. 2013;173(2):372–80. doi:10.1111/cei.12105.
Edgar JD, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, et al. The united kingdom primary immune deficiency (UKPID) registry: report of the first 4 years’ activity 2008–2012. Clin Exp Immunol. 2014;175(1):68–78. doi:10.1111/cei.12172.
Abuzakouk M, Feighery C. Primary immunodeficiency disorders in the republic of Ireland: first report of the national registry in children and adults. J Clin Immunol. 2005;25(1):73–7. doi:10.1007/s10875-005-0360-9.
Aghamohammadi A, Mohammadinejad P, Abolhassani H, Mirminachi B, Movahedi M, Gharagozlou M, et al. Primary immunodeficiency disorders in Iran: update and New insights from the third report of the national registry. J Clin Immunol. 2014;34(4):478–90. doi:10.1007/s10875-014-0001-z.
Al-Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait national primary immunodeficiency registry (2004--2006). J Clin Immunol. 2008;28(2):186–93. doi:10.1007/s10875-007-9144-5.
Garcia JM, Gamboa P, de la Calle A, Hernandez MD, Caballero MT, Garcia BE, et al. Diagnosis and management of immunodeficiencies in adults by allergologists. J investig Allergol Clin Immunol. 2010;20(3):185–94.
Lim DL, Thong BY, Ho SY, Shek LP, Lou J, Leong KP, et al. Primary immunodeficiency diseases in Singapore--the last 11 years. Singap Med J. 2003;44(11):579–86.
Barbouche MR, Galal N, Ben-Mustapha I, Jeddane L, Mellouli F, Ailal F, et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci. 2011;1238:42–52. doi:10.1111/j.1749-6632.2011.06260.x.
Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Costa-Carvalho BT, et al. Primary immunodeficiency diseases in Latin america: the second report of the LAGID registry. J Clin Immunol. 2007;27(1):101–8. doi:10.1007/s10875-006-9052-0.
Author information
Authors and Affiliations
Corresponding author
Additional information
Fethi Mellouli, Imen Ben Mustapha, Mohamed-Ridha Barbouche and Mohamed Bejaoui contributed equally to this work.
Rights and permissions
About this article
Cite this article
Mellouli, F., Mustapha, I.B., Khaled, M.B. et al. Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988–2012). J Clin Immunol 35, 745–753 (2015). https://doi.org/10.1007/s10875-015-0206-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-015-0206-9